Sign Up to like & get
recommendations!
3
Published in 2023 at "Journal of immunology"
DOI: 10.4049/jimmunol.2200611
Abstract: Gefitinib (GF), the tyrosine kinase inhibitor (TKI) targeting epidermal growth factor receptor, initiates lung inflammation through the NLR family pyrin domain containing 3 (NLRP3) inflammasome. However, the molecular targets and mechanisms underlying the inflammatory action…
read more here.
Keywords:
hypoactivity;
family;
mitochondrial src;
family kinases ... See more keywords